← All stocks

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Net selling
CIK 0000818686 #599 in the set updated 17 Sep 2026
Bought (120 mo)
$16.50M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$169.39M
$27.59M on a plan · $79.21M straight out of an exercise
Sold at will
$62.60M
106 of 303 sales
Net
−$152.90M
−$46.10M against sales at will

By person

42 insiders · 309 transactions
25.8×

Richard Francis holds 25.8 times base salary in stock. $43.86M of shares against $1.70M in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Francis last reported holding, valued at $37.25, the price Ordinary Shares was last bought or sold at on the open market here, on 21 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Francis Richard D
President and CEO
$34.82M (14) scheduled
−$34.82M
1,177,529
0.1010%
$43.86M
Sabag Mark
See "Remarks"
$25.95M (11)
−$25.95M
80,760
0.0069%
$3.01M
+73.4%
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$24.53M (8) scheduled
−$24.53M
65,621
0.0056%
$2.44M
Daniell Richard
EVP, Europe Commercial
$23.68M (52) scheduled
−$23.68M
55,755
0.0048%
$2.08M
MIGNONE ROBERTO
Director
$14.43M (2)
$23.60M (5)
−$9.16M
487,407
0.0418%
$18.16M
−35.0%
Hughes Eric A
See "Remarks"
$7.49M (14) scheduled
−$7.49M
134,877
0.0116%
$5.02M
Drape Eric
Executive VP Global Operations
$4.46M (22)
−$4.46M
145,915
0.0125%
$5.44M
+748.6%
Stark David Matthew
Exec. VP Chief Legal Officer
$4.35M (25) scheduled
−$4.35M
2,974
0.0003%
$110.80K
0.0%
Fridriksdottir Hafrun
Executive VP, Global R&D
$3.67M (29)
−$3.67M
1,387
0.0001%
$51.65K
−84.0%
Fox Christine
EVP, U.S. Commercial
$3.17M (8) scheduled
−$3.17M
63,647
0.0055%
$2.37M
Weiss Amir
Chief Accounting Officer
$2.30M (9)
−$2.30M
13,071
0.0011%
$486.89K
−9.2%
Lippman Evan
EVP, Business Development
$2.16M (3) scheduled
−$2.16M
25,591
0.0022%
$953.26K
Dethlefs Sven
EVP, North America Commercial
$43.84K (1)
$2.15M (20) scheduled
−$2.11M
165,381
0.0142%
$6.16M
+6,513%
BARER SOL J
Director
$2.00M (2)
+$2.00M
448,011
0.0384%
$16.69M
O'Grady Brendan P.
EVP, North America Commercial
$1.64M (20)
−$1.64M
14,868
0.0013%
$553.85K
+970.8%
Shields Matthew
EVP, Global Operations
$1.51M (4) scheduled
−$1.51M
0
0.0000%
$0.00
Nazzi Gianfranco
EVP, International Markets
$1.39M (16)
−$1.39M
0
0.0000%
$0.00
−100.0%
Jover Placid
See "Remarks"
$987.21K (3) scheduled
−$987.21K
6,774
0.0006%
$252.33K
Conway Vikki L
See "Remarks"
$339.24K (5)
−$339.24K
0
0.0000%
$0.00
de Notaristefani Carlo
Executive VP Global Operations
$337.42K (4)
−$337.42K
33,589
0.0029%
$1.25M
+1,130%
Griffin Deborah A
Chief Accounting Officer
$333.39K (13) scheduled
−$333.39K
0
0.0000%
$0.00
Savage Brian
Interim Chief Legal Officer
$163.76K (4) scheduled
−$163.76K
10,914
0.0009%
$406.55K
+1,377%
Codner Iris Beck
EVP Global Brand&Communication
$94.54K (1)
−$94.54K
17,996
0.0015%
$670.35K
+44.5%
Grant Angus
EVP, Business Development
$70.24K (1) scheduled
−$70.24K
8,848
0.0008%
$329.59K
McAvoy David R.
EVP, Chief Legal Officer
$20.99K (1)
$76.25K (2) scheduled
−$55.26K
13,027
0.0011%
$485.26K
Shani Eli
EVP,Global Marketing&Portfolio
$43.24K (1) scheduled
−$43.24K
54,228
0.0047%
$2.02M
+496.5%
McClellan Michael James
EVP, Chief Financial Officer
$36.10K (6) scheduled
−$36.10K
15,898
0.0014%
$592.21K
+53.9%
Crane Rosemary A
Director
$34.04K (1) scheduled
−$34.04K
127,739
0.0110%
$4.76M
+2,084%
Satchi-Fainaro Ronit
Director
$15.46K (1)
−$15.46K
111,986
0.0096%
$4.17M
Zaks Tal Zvi
Director
$592.71 (1)
−$592.71
73,247
0.0063%
$2.73M
+430,765%
Elstein Amir
Director
2,118,455
0.1818%
$78.91M
+6.3%
Schultz Kare
President and CEO
1,542,471
0.1324%
$57.46M
Suesskind Dan S
Director
318,836
0.0274%
$11.88M
+6.6%
LIEBERMAN GERALD M
Director
130,149
0.0112%
$4.85M
+2,310%
Nisen Perry
Director
119,807
0.0103%
$4.46M
Bergwerk Dov
Acting Chief Legal Officer
96,983
0.0083%
$3.61M
+7.4%
Vergis Janet S.
Director
73,697
0.0063%
$2.75M
Halfon Jean Michel
Director
63,707
0.0055%
$2.37M
Peres Nechemia Jacob
Director
58,765
0.0050%
$2.19M
Inbar Galia
See "Remarks"
46,011
0.0039%
$1.71M
+853.0%
Shalev Varda
Director
22,504
0.0019%
$838.27K
Lichtenstein Chen
Director
19,296
0.0017%
$718.78K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 594
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 177
Sales at will 106
Transactions with no price 0
Shares from compensation/vesting 11,877,292
Sales filed before the plan box existed 79
History held since 23 Jan 2018